資源描述：
《冠狀病毒Coronavirusl論文-2017 TMPRSS2_ A potential target for treatment of influenza virus and coronavirus infections.pdf》由會員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫。
1、AcceptedManuscriptTMPRSS2:ApotentialtargetfortreatmentofinfluenzavirusandcoronavirusinfectionsLiWenShen,HuiJuanMao,YanLingWu,YoshimasaTanaka,WenZhangPII:S0300-9084(17)30187-6DOI:10.1016/j.biochi.2017.07.016Reference:BIOCHI5247Toappearin:BiochimieReceivedDate:18Apri
2、l2017RevisedDate:0300-90840300-9084AcceptedDate:31July2017Pleasecitethisarticleas:L.W.Shen,H.J.Mao,Y.L.Wu,Y.Tanaka,W.Zhang,TMPRSS2:Apotentialtargetfortreatmentofinfluenzavirusandcoronavirusinfections,Biochimie(2017),doi:10.1016/j.biochi.2017.07.016.ThisisaPDFfileof
3、anuneditedmanuscriptthathasbeenacceptedforpublication.Asaservicetoourcustomersweareprovidingthisearlyversionofthemanuscript.Themanuscriptwillundergocopyediting,typesetting,andreviewoftheresultingproofbeforeitispublishedinitsfinalform.Pleasenotethatduringtheproducti
4、onprocesserrorsmaybediscoveredwhichcouldaffectthecontent,andalllegaldisclaimersthatapplytothejournalpertain.ACCEPTEDMANUSCRIPTABSTRACT:Influenzavirusandcoronavirusepidemicsorpandemicshaveoccurredinsuccessionworldwidethroughouttheearly21stcentury.Theseepidemicsorpan
5、demicsposeamajorthreattohumanhealth.Here,weoutlineacriticalroleofthehostcellproteaseTMPRSS2ininfluenzavirusandcoronavirusinfectionsandhighlightanantiviraltherapeuticstrategytargetingTMPRSS2.MANUSCRIPTACCEPTEDACCEPTEDMANUSCRIPTTMPRSS2:APotentialTargetforTreatmentofI
6、nfluenzaVirusandCoronavirusInfectionsaab,*ca,*LiWenShen,HuiJuanMao,YanLingWu,YoshimasaTanaka,WenZhangaLabofChemicalBiologyandMolecularDrugDesign,CollegeofPharmaceuticalScienceandInstituteofDrugDevelopment&ChemicalBiology,ZhejiangUniversityofTechnology,Hangzhou,3100
7、14,ChinabLabofMolecularImmunology,VirusInspectionDepartment,ZhejiangProvincialCenterforDiseaseControlandPrevention,Hangzhou,310051,ChinacCenterforInnovationinImmunoregulativeTechnologyandTherapeutics,GraduateSchoolofMedicine,KyotoUniversity,Kyoto,606-8501,Japan*Cor
8、respondingauthors:WenZHANG,LabofChemicalBiologyandMolecularDrugDesign,CollegeofPharmaceuticalScienceandInstituteofDrugDevelopment&ChemicalBiology
